Scientists hunt for hidden clues to predict deadly blood cancer
NCT ID NCT07214324
Summary
This study aims to understand why some early, symptomless blood conditions progress to a serious bone marrow cancer called multiple myeloma. Researchers will analyze blood, bone marrow, and saliva samples from 60 patients to look for biological markers that signal high risk. The goal is to improve early detection and help design future prevention strategies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA (MM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Istituto Ortopedico Rizzoli IRCCS
Bologna, Italy
-
S.C Ematologia - Azienda USL IRCCS di Reggio Emilia
Reggio Emilia, Italy
-
UO Ematologia Azienda Ospedaliero-Universitaria "Policlinico Rodolico San Marco"
Catania, Italy
-
UOC di Ematologia, Dipartimento di Oncologia, AOU Policlinico "Paolo Giaccone"
Palermo, Italy
Conditions
Explore the condition pages connected to this study.